← Back to Screener
ALT5 Sigma Corporation Common Stock (ALTS)
Price$0.85
Value ScoreC
Growth ScoreD
Momentum ScoreF
Favorite Metrics
Price vs S&P 500 (26W)-73.93%
Price vs S&P 500 (4W)-35.14%
VGM Score32.60
Market Capitalization$108.73M
All Metrics
P/CF (Annual)66.25x
Book Value / Share (Quarterly)$9.14
P/TBV (Annual)0.13x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-14.40%
Cash Flow / Share (Quarterly)$-0.06
Price vs S&P 500 (YTD)-50.37%
Gross Margin (TTM)41.01%
Net Profit Margin (TTM)-1386.90%
EPS (TTM)$-3.41
10-Day Avg Trading Volume1.57M
EPS Excl Extra (TTM)$-3.41
Revenue Growth (5Y)-6.03%
EPS (Annual)$-5.91
ROI (Annual)-29.42%
Gross Margin (Annual)41.01%
Net Profit Margin (5Y Avg)-297.37%
Cash / Share (Quarterly)$0.05
P/E Basic Excl Extra (TTM)3.55x
Revenue Growth QoQ (YoY)-0.90%
ROA (Last FY)-28.25%
Revenue Growth TTM (YoY)98.21%
EBITD / Share (TTM)$-0.25
ROE (5Y Avg)-87.84%
Operating Margin (TTM)-94.17%
Cash Flow / Share (Annual)$-0.06
P/B Ratio0.09x
P/B Ratio (Quarterly)0.12x
Net Income / Employee (Annual)$-34,450,700
EV / Revenue (TTM)4.74x
Net Interest Coverage (TTM)-0.06x
ROA (TTM)-45.45%
EPS Incl Extra (Annual)$-5.91
Current Ratio (Annual)0.57x
Quick Ratio (Quarterly)0.53x
3-Month Avg Trading Volume2.66M
52-Week Price Return-93.47%
EV / Free Cash Flow (Annual)72.08x
P/E Incl Extra (TTM)3.55x
Revenue / Employee (TTM)$2,484,000
Tangible BV / Share (Quarterly)$8.96
P/S Ratio (Annual)4.38x
Asset Turnover (Annual)0.02x
52-Week High$10.95
Operating Margin (5Y Avg)-37.53%
EPS Excl Extra (Annual)$-5.91
CapEx CAGR (5Y)-57.88%
26-Week Price Return-66.01%
Quick Ratio (Annual)0.53x
13-Week Price Return-55.55%
Total Debt / Equity (Annual)0.01x
Current Ratio (Quarterly)0.57x
Enterprise Value$117.76M
Revenue / Share Growth (5Y)-52.62%
Asset Turnover (TTM)0.03x
Revenue / Employee (Annual)$2,484,000
Inventory Turnover (Annual)21.97x
Pretax Margin (Annual)-1723.95%
Cash / Share (Annual)$0.05
3-Month Return Std Dev89.94%
Gross Margin (5Y Avg)30.70%
Net Income / Employee (TTM)$-34,450,700
ROE (Last FY)-29.81%
Net Interest Coverage (Annual)-0.01x
EPS Basic Excl Extra (Annual)$-5.91
P/FCF (TTM)13.08x
Receivables Turnover (TTM)38.53x
Total Debt / Equity (Quarterly)0.01x
EPS Incl Extra (TTM)$-3.41
Receivables Turnover (Annual)8.10x
ROI (TTM)-48.56%
P/S Ratio (TTM)4.38x
Pretax Margin (5Y Avg)-366.61%
Revenue / Share (Annual)$0.43
Tangible BV / Share (Annual)$8.96
Price vs S&P 500 (52W)-117.84%
P/E Ratio (TTM)3.55x
Year-to-Date Return-42.21%
5-Day Price Return-26.08%
EPS Normalized (Annual)$-5.91
ROA (5Y Avg)-33.68%
Net Profit Margin (Annual)-1386.90%
Month-to-Date Return-25.30%
EBITD / Share (Annual)$-0.34
Operating Margin (Annual)-91.99%
LT Debt / Equity (Annual)0.01x
ROI (5Y Avg)-37.78%
P/E Excl Extra (TTM)3.55x
LT Debt / Equity (Quarterly)0.01x
EPS Basic Excl Extra (TTM)$-3.41
P/TBV (Quarterly)0.13x
P/B Ratio (Annual)0.12x
Inventory Turnover (TTM)19.82x
Pretax Margin (TTM)-1726.12%
Book Value / Share (Annual)$9.14
Price vs S&P 500 (13W)-63.80%
Beta1.81x
P/FCF (Annual)61.19x
Revenue / Share (TTM)$0.20
ROE (TTM)-49.78%
52-Week Low$0.63
vGradeC
gGradeD
mGradeF
vgmGradeD
Show chart for
Analyst Recommendations
Dec 2025
Jan 2026
Feb 2026
Mar 2026
4.14
4.14
4.14
4.14
Industry Peers — Commodity Contracts(125)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ALTSALT5 Sigma Corporation Common Stock | C | D | F | $0.85 |
| GBTCGrayscale Bitcoin Trust ETF | — | — | F | $46.80 |
| PHYSSprott Physical Gold Trust | C | A | C | $32.54 |
| ETHEGrayscale Ethereum Staking ETF Shares | A | — | F | $12.75 |
| SPPPSprott Physical Platinum and Palladium Trust | B | A | C | $13.68 |
| UROYUranium Royalty Corp. Common Stock | F | A | D | $3.09 |
| GDLCGrayscale CoinDesk Crypto 5 ETF | — | — | F | $26.91 |
| ANTAAntalpha Platform Holding Company Class A Ordinary Shares | B | A | D | $7.09 |
| AIBBlockchAIn Digital Infrastructure, Inc | F | F | C | $1.65 |
| AIFCAI Financial Corporation Common Stock | C | D | F | $0.64 |
| AAAUGoldman Sachs Physical Gold ETF Shares | — | — | C | $42.57 |
About
ALT5 Sigma Corp is a fintech company offering blockchain-enabled solutions for digital asset tokenization, trading, clearing, settlement, and custody. Its biotechnology division focuses on developing non-addictive pain-relief treatments. The company generates revenue primarily from its fintech operations.